Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • UBS analyst Weston Bloomer upgraded Arthur J. Gallagher & Co. (NYSE:AJG) from Neutral to Buy and lowers the price target from $283 to $250. Arthur J. Gallagher shares closed at $212.52 on Monday. See how other analysts view this stock.
  • Sidoti & Co. analyst Steve Ferazani upgraded Brady Corp (NYSE:BRC) from Neutral to Buy and announced a $103 price target. Brady shares closed at $75.28 on Monday. See how other analysts view this stock.
  • GLJ Research analyst Gordon L. Johnson upgraded Cleveland-Cliffs Inc (NYSE:CLF) from Sell to Hold and raised the price target from $9.03 to $15.01. Cleveland-Cliffs shares closed at $12.68 on Monday. See how other analysts view this stock.
  • JP Morgan analyst Ella Smith upgraded PAR Technology Corporation (NYSE:PAR) from Underweight to Neutral and raised the price target from $12 to $16. PAR Technology shares closed at $13.28 on Monday. See how other analysts view this stock.
  • Barclays analyst Luke Sergott upgraded West Pharmaceutical Services, Inc. (NYSE:WST) from Equal-Weight to Overweight and raised the price target from $310 to $400. West Pharmaceutical shares closed at $319.75 on Monday. See how other analysts view this stock.

Considering buying BRC stock? Here’s what analysts think:

Photo via Shutterstock